NCT01931449

Brief Summary

The purpose of this study is to evaluate the validity and safety of a modified operative procedure of digestive tract reconstruction following pancreatoduodenectomy which enables the pancreatic juice and bile to bypass at the pancreatointestinal anastomosis and merge at gastrointestinal anastomosis. It is anticipated that this procedure can decrease the risk of post-surgical pancreatic leakage and preserve the patients' digestive function as well.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P25-P50 for phase_3 pancreatic-cancer

Timeline
Completed

Started Jan 2014

Shorter than P25 for phase_3 pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 29, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

August 29, 2013

Status Verified

August 1, 2013

Enrollment Period

11 months

First QC Date

August 21, 2013

Last Update Submit

August 26, 2013

Conditions

Keywords

PancreatoduodenectomyDigestive Tract ReconstructionPancreas

Outcome Measures

Primary Outcomes (1)

  • Incidence of Pancreatic Leakage

    up to 12 months

Secondary Outcomes (2)

  • Life Quality Score

    up to 12 months

  • Amylase Test of Abdominal Drainage Fluid

    up to 3 months

Other Outcomes (3)

  • Anesthesia Score

    up to 12 months

  • Length of Hospital Stay

    up to 12 months

  • Re-surgery Rate

    up to 12 months

Study Arms (2)

Modified digestive reconstruction

EXPERIMENTAL

Modified method of digestive tract reconstruction: Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract with an independent intestinal loop and pancreas end.

Procedure: Modified method of digestive tract reconstruction

Routine pancreatoduodenectomy

ACTIVE COMPARATOR

Routine digestive tract reconstruction: Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes;Reconstruct the common bile duct-jejunum and pancreatic duct-jejunum respectively.

Procedure: Routine digestive tract reconstruction

Interventions

Modified digestive reconstruction
Routine pancreatoduodenectomy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Below 80 years old
  • CT (Computed Tomography), CTA (Computed Tomographic Angiography), MRI (Magnetic Resonance Imaging) or ultrasonic test suggested pancreatic head carcinoma, periampullary carcinoma, chronic pancreatitis with intractable pain, pancreatic head mass which unable to rule out pancreatic cancer, with or without obstructive jaundice/chronic abdominal pain.

You may not qualify if:

  • Liver Metastasis
  • Metastasis in common bile duct and hepatic duct
  • Extensive lymph node metastasis, metastasis at hepatic portal or above pancreas
  • Pancreatic head or periampullary has tight adhesion with postcava or aorta
  • Distant metastasis
  • Poor physical condition to tolerate anesthesia and surgery (e.g. severe cardio-pulmonary diseases, blood coagulation disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institution of Hepatobiliary Surgery, Southwest Hospital

Chongqing, Chongqing Municipality, 400038, China

Location

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Huai-zhi Wang, M.D., Ph.D.

    Southwest Hospital, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Huai-zhi Wang, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 21, 2013

First Posted

August 29, 2013

Study Start

January 1, 2014

Primary Completion

December 1, 2014

Study Completion

July 1, 2015

Last Updated

August 29, 2013

Record last verified: 2013-08

Locations